Education
About Us
Working with TipRanks
Follow Us
Adverum Biotechnologies (ADVM)
:ADVM
ADVM Analyst Ratings
Strong Buy
3 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ADVM Stock 12 Month Forecast
Average Price Target
$17.00
▲(509.32%Upside)
| Highest Price Target$30.00 | Average Price Target$17.00 | Lowest Price Target$4.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$2.5
Sell
-10.39%
Downside
Reiterated
06/07/25
Adverum Biotechnologies' overall stock score is predominantly affected by its poor financial performance and bearish technical indicators. The negative P/E ratio further highlights valuation concerns. The subtenant default situation adds potential operational risks, requiring close monitoring. Immediate improvements in financial health and strategic adjustments are essential for enhancing the stock's prospects.
TD Cowen
―
Buy
―
Reiterated
05/15/25
H.C. Wainwright
$30
Buy
975.27%
Upside
Reiterated
05/15/25
RBC Capital
$5→$4
Hold
43.37%
Upside
Reiterated
05/14/25
Truist Financial
―
Buy
―
Initiated
04/21/25
Mizuho Securities
―
Buy
―
Reiterated
02/10/25
Oppenheimer
$28
Buy
903.58%
Upside
Reiterated
11/05/24
Chardan Capital
―
Buy
―
Reiterated
10/16/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$2.5
Sell
-10.39%
Downside
Reiterated
06/07/25
Adverum Biotechnologies' overall stock score is predominantly affected by its poor financial performance and bearish technical indicators. The negative P/E ratio further highlights valuation concerns. The subtenant default situation adds potential operational risks, requiring close monitoring. Immediate improvements in financial health and strategic adjustments are essential for enhancing the stock's prospects.
TD Cowen
―
Buy
―
Reiterated
05/15/25
H.C. Wainwright
$30
Buy
975.27%
Upside
Reiterated
05/15/25
RBC Capital
$5→$4
Hold
43.37%
Upside
Reiterated
05/14/25
Truist Financial
―
Buy
―
Initiated
04/21/25
Mizuho Securities
―
Buy
―
Reiterated
02/10/25
Oppenheimer
$28
Buy
903.58%
Upside
Reiterated
11/05/24
Chardan Capital
―
Buy
―
Reiterated
10/16/24
Best Analysts Covering Adverum Biotechnologies
1 Month
xxx
Success Rate
6/16 ratings generated profit
Average Return
+4.06%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 37.50% of your transactions generating a profit, with an average return of +4.06% per trade.
3 Months
xxx
Success Rate
5/14 ratings generated profit
Average Return
-2.92%
initiated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 35.71% of your transactions generating a profit, with an average return of -2.92% per trade.
1 Year
2 Years
xxx
Success Rate
1/14 ratings generated profit
Average Return
-65.84%
initiated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 7.14% of your transactions generating a profit, with an average return of -65.84% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ADVM Analyst Recommendation Trends
Rating
Oct 24
Nov 24
Feb 25
Apr 25
May 25
Strong Buy
9
10
8
5
2
Buy
5
5
5
6
4
Hold
1
1
1
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
15
16
14
13
8
Each month's total comprises the sum of three months' worth of ratings.
ADVM Financial Forecast
ADVM Stock Forecast FAQ
What is ADVM’s average 12-month price target, according to analysts?
Based on analyst ratings, Adverum Biotechnologies’s 12-month average price target is 17.00.
What is ADVM’s upside potential, based on the analysts’ average price target?
Adverum Biotechnologies has 509.32% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ADVM a Buy, Sell or Hold?
Adverum Biotechnologies has a consensus rating of Strong Buy which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
What is Adverum Biotechnologies’s price target?
The average price target for Adverum Biotechnologies is 17.00. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $30.00 ,the lowest forecast is $4.00. The average price target represents 509.32% Increase from the current price of $2.79.
The highest analyst price target is $30.00 ,the lowest forecast is $4.00. The average price target represents 509.32% Increase from the current price of $2.79.
What do analysts say about Adverum Biotechnologies?
Adverum Biotechnologies’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of ADVM?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.